Click image to zoom

Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)

Photo Details

Photo ID	#11661394
Date Taken	13 October 2024
Location	N/A
Photographer	Artur Widak/NurPhoto
Category	Economy, Business and Finance
Copyright	© 2026 NurPhoto - Artur Widak/NurPhoto

Related Keywords

Acquisition Agreement Assets Billion Brand Business Buyout CD&R Capital Clayton Clayton Dubilier & Rice Commercial Company Competition Consumer-products Corporate Deal Deal-structure Divestment Doliprane Dubilier Equity Europe Euros Exit Expansion Financial France Fund Global Growth Health Healthcare Industry Innovation Integration Investment-fund Market Medicine Merger Opella Over-the-counter Ownership Painkillers Portfolio Pricing Restructure Rice Sale Sanofi Strategy Synergy Transaction Transfer USA Valuation consumer investment move pharmaceutical products profit revenue strategic Bayeux France Doliprane Sanofi pharmaceutical divesting consumer healthcare Opella consumer health products Clayton Dubilier and Rice CDandR investment fund 15 billion euros Calvados computer screen Sanofi logo American investment divestment healthcare division business sale October 13 2024 world's fifth-largest pharmaceutical company France Doliprane 1000g boxes sale business transaction investment healthcare euros acquisition Opella sale.

License This Photo

Digital Basic Editorial use on digital platforms only (websites, social media). Single use, up to 1 million monthly UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€35.00

Editorial Print & Digital For editorial use in print and digital publications such as newspapers, magazines, and textbooks. Single use, up to 10,000 copies or 1 million UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€99.00

Broadcast (TV & Digital) For editorial use in TV production or streaming platforms. Single use, all media rights excluding theatrical, with worldwide distribution in perpetuity. NO COMMERCIAL OR PROMOTIONAL USE

€399.00

Total Price

€35.00

Secure checkout

Need a custom license?

Contact Sales